CODX
Mosquito season, but make it a business model
Co-Diagnostics just said it completed two new Vector Smart® laboratory installations in Florida, with another install and customer training underway in Indiana. In plain English: the company is trying to turn mosquito surveillance into a real, repeatable revenue stream, not just a science project with a nice logo.
Why investors should care
Florida is dealing with a very real dengue problem right now — state surveillance has logged 73 locally acquired cases and 14 dengue-positive mosquito pools this season. That gives Co-Dx’s pitch a little extra juice, because nobody wants to be the person explaining why mosquito testing was optional.
The setup suggests a few things:
- more customer deployments for Vector Smart
- a broader footprint beyond one state
- a product tied to public-health urgency, which can help sales conversations move faster
The bigger picture
This is still a small-company story, not a blockbuster contract announcement. But if Co-Diagnostics can keep stacking installs while disease surveillance demand rises, it could help prove the platform has legs.
Big picture: sometimes the best-selling product is the one helping people find the bug before the bug finds them.